GOut TrEatment STrategy (GO TEST) FINALE study, a multicentre pragmatic randomized superiority trial of continuation versus cessation of urate lowering therapies in gout in remission.
The GO TEST FINALE study aims to find the best long-term treatment strategy for people whose gout is currently well-controlled. If your gout is in remission (meaning you haven't had recent flare-ups), doctors are trying to understand if you should continue taking your existing gout medicines, like allopurinol, benzbromarone, or febuxostat, or if it's safe and beneficial to stop them. This study will follow participants for 24 months, observing how many remain free from gout flare-ups over the last six months of the study. It's a large study involving many different clinics, designed to give clear answers to this important question for gout patients in the UK.
Överblick
Vad handlar denna studie om?
The GO TEST FINALE study is a very important research project looking into the best way to manage gout for the long term. Many people take medication to keep their gout under control, and when it's settled and they're not having flare-ups, it's called being in 'remission'. This study wants to find out what happens if these people either continue taking their gout medication or if they stop taking it.
The main goal is to see if continuing your medication, even when you feel well, is better than stopping it. Researchers will be comparing different common gout medicines, such as allopurinol, benzbromarone, and febuxostat. This research is a 'Phase IV' study, which means these are already approved medications and doctors are studying the best way to use them in real-world situations, rather than testing completely new drugs.
The results of this study could help doctors make clearer recommendations about how long people should take their gout medication after their condition has settled. This could make a big difference to how gout is managed for many people across the UK, potentially reducing the need for unnecessary medication or preventing future flare-ups.
Viktiga punkter
- The study explores if people with well-controlled gout can safely stop their medication.
- It lasts for two years and compares continuing vs. stopping standard gout medicines.
- Participation involves regular check-ups to monitor your gout.
- It aims to provide important answers for long-term gout management.
- Du kan dra dig ur studien när som helst.
Vem kan vara berättigad?
To join this study, you need to be an adult, 18 years old or older. There is no upper age limit, so people of all adult ages can take part.
This study is for both men and women, as gout can affect anyone.
Most importantly, you must have gout that is currently well-controlled, meaning you haven't had recent flare-ups and your doctor considers it to be in remission. The study will look more closely at your specific medical history to make sure it's suitable for you.
Kan denna studie passa dig?
Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.
- Är du 18 år eller äldre?
- Do you have a diagnosis of gout?
- Is your gout currently well-controlled (in remission)?
- Are you currently taking medication for your gout?
Vad innebär deltagande?
If you join the study, you will be randomly put into one of two groups: one group will continue taking their current gout medication, and the other group will stop taking it. You won't get to choose which group you are in, as this helps make the study fair.
You will be followed for a total of two years (24 months). During this time, you'll have regular check-ups and assessments, likely at your local clinic, to see how your gout is doing. These check-ups will help the study team understand if your gout stays in remission, or if you have any flare-ups.
The study will focus on what happens in the last six months of the two-year period. You'll need to attend all scheduled appointments so that the researchers can get a full picture of your health and the effects of the treatment.
Potentiella risker och fördelar
Platser (1)
- —ObekräftadNederländerna
Vanliga frågor
What kind of medication will I be taking?
You'll either continue taking your current gout medication (like allopurinol, benzbromarone, or febuxostat) or stop taking it, depending on which group you're in.
Hur länge kommer studien att pågå om jag deltar?
The study will follow you for a total of two years (24 months).
Will I have to pay for anything if I'm in the study?
Usually, clinical trials cover the costs related to the study, such as specific medications or appointments. This should be confirmed by the study team.
Kan jag lämna studien när som helst?
Yes, you are completely free to withdraw from the study at any point, and it won't affect your regular medical care.
What does 'gout in remission' mean?
It means your gout is currently well-controlled, and you haven't had any recent gout flare-ups or symptoms.
Hur du får reda på mer
Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.
Intresserad av att delta?
Diskussion
Gemenskapsdiskussion
Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.